| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Previous Article | Next Article ![]()
Infection and Immunity, August 2008, p. 3628-3631, Vol. 76, No. 8
0019-9567/08/$08.00+0 doi:10.1128/IAI.00471-08
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

G. Christian Baldeviano,
Michael G. Overstreet, and
Fidel Zavala*
Department of Molecular Microbiology and Immunology, Malaria Research Institute, Bloomberg School of Public Health, Johns Hopkins University, 615 N. Wolfe Street, Baltimore, Maryland 21205
Received 15 April 2008/ Returned for modification 14 May 2008/ Accepted 22 May 2008
The protective immune response against liver stages of the malaria parasite critically requires CD8+ T cells. Although the nature of the effector mechanism utilized by these cells to repress parasite development remains unclear, a critical role for gamma interferon (IFN-
) has been widely assumed based on circumstantial evidence. However, the requirement for CD8+ T-cell-mediated IFN-
production in protective immunity to this pathogen has not been directly tested. In this report, we use an adoptive transfer strategy with circumsporozoite (CS) protein-specific transgenic T cells to examine the role of CD8+ T-cell-derived IFN-
production in Plasmodium yoelii-infected mice. We show that despite a marginal reduction in the expansion of naive IFN-
-deficient CS-specific transgenic T cells, their antiparasite activity remains intact. Further, adoptively transferred IFN-
-deficient CD8+ T cells were as efficient as their wild-type counterparts in limiting parasite growth in naive mice. Taken together, these studies demonstrate that IFN-
secretion by CS-specific CD8+ T cells is not essential to protect mice against live sporozoite challenge.
Published ahead of print on 2 June 2008.
Present address: Sanaria, Inc., 9800 Medical Center Drive, Rockville, MD 20850.
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|